Viatris Inc. (VTRS) Key Statistics & Financial Ratios

Viatris Inc. (VTRS) — Price $17.60 — Healthcare — Drug Manufacturers - Specialty & Generic — NASDAQ

Latest reported results:

Key statistics dashboard for Viatris Inc. (VTRS). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

Viatris Inc. operates as a global pharmaceutical and healthcare enterprise. Its business is structured across four primary geographic divisions: Developed Markets, Greater China, JANZ (Japan, Australia, New Zealand), and Emerging Markets. The company offers a comprehensive range of pharmaceutical products, encompassing branded prescription medications, generic and complex generic drugs, biosimilar treatments, and active pharmaceutical ingredients (APIs).

Stock Data

Price$17.60
Market Cap$20.5B
Beta0.82
ExchangeNASDAQ
CountryUS

Valuation Multiples

P/E Ratio-48.94
Price / Book1.44
P/S1.39
P/FCF10.95
Dividend Yield2.73%

Profitability

Gross Margin34.83%
EBIT Margin-0.59%
EBITDA Margin17.92%
Operating Margin-0.59%
Net Margin-2.79%

Financial Health

Current Ratio1.58
Quick Ratio0.96
Cash Ratio0.14
Debt / Equity0.96
Debt / Assets38.88%
Interest Coverage-0.18
Piotroski F-Score5
Altman Z-Score0.59

Per-Share Data

Revenue per share12.67
Book Value per share12.26
Cash per share1.30
FCF per share1.61
Tangible Book Value per share-5.22
Dividend per share0.48

Analyst Consensus

Strong Buy0
Buy4
Hold8
Sell1
Strong Sell0
Total analysts13
Avg rating (1-5)0.23

Related companies: BAX · BBIO · ELAN · EXAS · IONS · MRNA · NBIX

Explore sector: Healthcare · Drug Manufacturers - Specialty & Generic

More sections of VTRS: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks